Dopamine levels are NOT insufficient in people with Parkinson’s
News flash from Cision PR Newswire: “Trailblazing medical researcher Dr. Jonathan Sackner-Bernstein offers a new theory about the causes (and potential treatments) for Parkinson’s, which could upend the prevailing treatments for the disease.”
To summarize his findings:
Dopamine levels are NOT insufficient in people with Parkinson’s. In people with Parkinson’s, dopamine levels are building up to ultra-high levels inside certain brain cells. This finding calls into question the current method of treating Parkinson’s, which is to force more dopamine into the brain. The author of the article says that the pharmaceutical dopamine-enhancing therapies currently in use for Parkinson’s “is akin to whipping a tired horse; it helps for a few strides but doesn’t affect long-term results.”
As an aside, it has never been proven that people with Parkinson’s have insufficient dopamine. This erroneous conclusion was merely inferred. It was based on the observation that, when given a high dose of pharmaceutical dopamine, people with Parkinson’s could temporarily move more easily.
This article further supports the conclusions of Dr. J. Hadlock, who notes that people with Parkinson’s disease are using a neurological mode that inhibits release of both dopamine (for motor function) and adrenaline. This release-inhibition is possibly what causes the build-up of cellular dopamine that has been confirmed by Dr. Sachner-Bernstein’s research.